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Lighter touch
Some years ago the decision to try to lighten the image of the
SAMJ by the addition of pictures to the front cover was greeted
with derision by several of our more senior colleagues. It was
said that the gravity of the Journal would be compromised and
after all the BMJ did not do so — but the BMJ too followed this
pattern some time later. Our recent change from a long vertical
picture along the side of the journal to a more conventional
centrally placed ‘landscape’ format has allowed for more
flexibility in the type of pictures used. Printing deadlines often
result in the choice of the cover picture being a rushed affair
and the content may not lend itself to suitable pictorial
representation. Hence the decision to print something different
in this issue. The front cover is courtesy of Marijke Maree, one
of our technical editors, from one of her rambles in the wilds
with her husband Sam. Those who have been there will
recognize the typical landscape of the Richtersveld. Should any
colleagues have a picture that they would like to see on the
cover, please send it to us for consideration.
We also welcome short ‘fillers’, which may be serious,
humorous, artistic or poetic. Dr Vaughan Williams has
supplied us with such an example (p. 762).
We hesitate to encourage the submission of longer pieces
such as the column of irregular habits from Robert-Ian to his
‘Dear Aunt Ethel’ (p. 763). The only reason is that few of us
have the ability to entertain consistently and to tickle the
humour buds. But if you wish to try we would also be happy
to put such submissions through the hoop.
Finally, from lightening the mood it is our pleasure to
announce that the Publications Committee has agreed that
pockets will not be lightened, as there will no longer be page
charges for articles accepted for publication!
Intrauterine growth and beyond
The commentary on intrauterine growth and disease in later
life by Geoffrey Bihl provides a further fascinating perspective
on the eternal debate on what influences us most, nature or
nurture (p. 757). 
Coronary heart disease (CHD), hypertension and diabetes
mellitus occur in epidemic proportions worldwide. Unhealthy
lifestyle practices and behaviours are well accepted as
contributing factors, but the true origins of these diseases may
actually be found in utero. According to the Barker hypothesis,
disturbed intrauterine growth has a negative influence on the
development of the cardiovascular system and favours the
occurrence of hypertension, insulin resistance,
hypercholesterolaemia and hyperuricaemia later in life.
Numerous studies have shown an inverse relationship
between the birth weight of infants and the increased incidence
of hypertension, CHD, impaired glucose tolerance, insulin
resistance and type 2 diabetes mellitus.
Many chronic disease of later life may be related to two
seemingly opposing factors potentially present early in life: 
(i) poverty, i.e. malnourished mothers give birth to
malnourished infants with low birth weights; and 
(ii) prosperity, i.e. exposure of an infant with a low birth weight
to a high-energy diet. These factors contribute to the biological
phenomenon of developmental plasticity, or the ability of a
genotype to produce multiple forms and behaviours in
response to environmental conditioning. 
For the litigation-conscious, is there yet another target to sue?
Osteoporosis and new anabolic
agents
Stephen Hough describes himself as a dour academic in the
endocrine unit at the University of Stellenbosch — not a fair
description for anyone who has experienced his friendly
demeanour and sense of humour! However it is nice to have
someone who can supply sense and authority on the important
topic of osteoporosis and the new anabolic agents used in its
treatment (p. 754).
The mainstay of current therapies for osteoporosis are
antiresorptive agents such as calcium and vitamin D,
oestrogen, selective oestrogen modulators, the bisphosphonates
and calcitonin. These agents inhibit osteoclast-mediated bone
loss, reduce bone turnover (both resorption and formation) and
modestly increase bone mineral density. Ideally, antiresorptive
agents should be employed to prevent osteoporosis, whereas
osteoanabolic agents, either alone or in combination with
antiresorptives, should be used to treat established disease.
Sodium fluoride markedly stimulates bone formation and
increases axial bone mineral density. While it has the potential
to be a useful drug in the treatment of osteoporosis, further
clinical trials are necessary before its routine use can be
recommended.
Further work needs to be done on growth hormone, insulin-
like growth factor 1 and statins. Strontium ranelate holds much
promise as a new anabolic agent in the management of
osteoporosis.
Intermittent, low-dose parathyroid hormone administration
causes rapid stimulation of bone formation, which results in a
marked increase in bone mass and strength, improvement in
trabecular microarchitecture and cortical geometry and a
significant reduction in the risk of vertebral as well as non-
vertebral fractures. Parathyroid hormone (PTH (1-34) or
teriparatide) will soon be available for osteoporosis treatment
in South Africa. Since the local cost of this product will be high,
serious ethical dilemmas will again be posed with regard to the
allocation of expensive resources.
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